穴位贴敷联合铝碳酸镁及补液治疗妊娠剧吐疗效观察

目的 观察穴位贴敷联合铝碳酸镁及补液治疗对妊娠剧吐孕妇的疗效。方法 将69例妊娠剧吐孕妇分为穴位贴敷组(穴位贴敷联合铝碳酸镁及常规补液)30例和对照组(铝碳酸镁联合常规补液)39例，观察并比较两组孕妇住院时间，治愈时间，尿酮体转阴率时间，两组孕妇尿酮体转阴率，二次住院率，治疗前后妊娠-呕吐与恶心独特量表(pregnancy-unique quantification of emesis and nausea, PUQE)评分，症状评分，妊娠呕吐生活质量(nausea and vomiting of pregnancy quality of life, NVPQOL)评分及临床疗效。结果 与对照组比较，穴位贴敷组孕妇住院时间、治愈时间及尿酮体转阴时间均显著减少(P<0.05)。两组孕妇尿酮体转阴率比较，差异有统计学意义(P<0.05)。治疗后两组PUQE评分均较前一时点显著减少(P<0.05),从治疗第2天起，穴位贴敷组PUQE评分均显著低于对照组(P<0.05)。治疗后两组孕妇症状评分、NVPQOL各项目评分均较治疗前显著减少(P<0.05),且穴位贴敷组...

Clinical Effect of Acupoint Application Combined with Hydrotalcite and Fluid Replacement in Treatment of Hyperemesis Gravidarum

Objective To investigate the clinical effect of acupoint application combined with hydrotalcite and fluid replacement in the treatment of hyperemesis gravidarum. Methods A total of 69 pregnant women with hyperemesis gravidarum were divided into acupoint application group (acupoint application+hydrotalcite+conventional fluid replacement) with 30 women and control group (hydrotalcite+conventional fluid replacement) with 39 women. The two groups were compared in terms of length of hospital stay, cure time, time to clearance of urine acetone bodies, clearance rate of urine acetone bodies, rate of rehospitalization, and clinical outcome, as well as PUQE score, symptom score, and NVPQOL score before and after treatment. Results Compared with the control group, the acupoint application group had significantly shorter length of hospital stay, cure time, and time to clearance of urine acetone bodies (P<0.05). There was a significant difference in the clearance of urine acetone bodies between the two groups (P<0.05). After treatment, both groups had a significant reduction in PUQE score compared with the previous time point (P<0.05), and since day 2 of treatment, the acupoint application group had a significantly lower PUQE score than the control group (P<0.05). After treatment, both groups had significant reductions in symptom score and the scores of each item of NVPQOL (P<0.05), and the acupoint application group had significantly greater reductions than the control group (P<0.05). The acupoint application group had a significantly better clinical outcome than the control group (P<0.05). Conclusion In pregnant women with hyperemesis gravidarum, acupoint application combined with hydrotalcite and fluid replacement can effectively reduce length of hospital stay, time to symptom relief, and time to the reduction in acetone bodies, effectively alleviate the symptoms of vomiting, and improve quality of life.